Gilead Sciences GesmbH

Wagramer Strasse 19 
1220 Wien
Austria

Phone: 43 (0) 1260 83 0
Fax: 43 (0)1 260 83 99

Drug Safety/Adverse Event Reporting

Phone: +43 (0) 1 260 83-0
Fax: +43 (0) 1 260 83-99
E-Mail: AustriaSafetyMailbox@gilead.com






Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Gilead's Vienna office opened in 2007. It is responsible for Gilead's commercial operations in Austria. The team is committed to offering and maintaining high-quality service to the medical community and is focused on the distribution of our products throughout the country.

Transparency Reporting
In line with local Transparency Reporting requirements, Gilead is disclosing its interactions with HealthCare Professionals and HealthCare Organisations in Austria in the following report, supported by a Methodological Note. Enquiries about the report should be directed to: http://www.gilead.com/news/media-inquiries.

Gilead Sciences Austria EFPIA Report 2015
Gilead Sciences Austria EFPIA Methodological Note 2015

Relationships with Health-related Institutions and Patient Organizations

Gilead provided support for the following Health-related Institutions and Patient Organizations in 2015. The information is correct at the time of writing (March 2016). The information is subject to change and will be updated accordingly. For a listing of previous years’ support, click here.

  • Grant Recipient
    Description of Activity
    Amount Funded €
  • Aids Hilfe Vorarlberg
    Sponsoring "Gesundheitstag"
    2,793.00
  • Aids Hilfe Wien
    Sponsoring Wiener AIDS Tag 2014
    1,250.00
  • Aids Hilfe Wien
    Execution of project "HIV and your body"
    7,060.00
  • Aids Hilfe Wien
    HIV-Testwoche
    6,000.00
  • Caritas der Diözese Graz-Seckau
    support of the educational project and Screening hep C in PWIDs
    9,600.00
  • Diakonie Flüchtlingsdienst gem GmbH/AmberMed
    support the project: treatment of uninsured patients with chronic hepatitis B
    7,500.00
  • Hepatitis Hilfe Österreich
    support of the general advice bureau
    15,000.00
  • Hepatitis Hilfe Österreich
    Patient brochure Hepatitis
    2,400.00
  • Hepatitis Hilfe Österreich
    Shuttleservice for Hepatitis C Patients from Graz to LKH Hörgas Enzenbach
    3,500.00
  • Medizinische Universität Graz
    Books for department library of Hepatology
    960.00
  • Medizinische Universität Wien
    study the effect of idelalisib on leukemia and Iymphoma cells in vitro
    10,000.00
  • Medizinische Universität Wien
    support of genetic investigations of chronic liver diseases
    25,000.00
  • Medizinische Universität Wien
    Makrozoonosis Research proposal, An Austrian Cohort of Patients with Echinoccosis
    2,000.00
  • Medizinische Universität Wien
    Ensuring of the quality at the liver pathology
    15,000.00
  • Medizinische Universität Wien
    support of the International Hans Popper Lectureship
    2,500.00
  • Medizinische Universität Wien
    Project on TP53 mutations in CLL (in particular comparing of the mutationanalysis using Sanger sequencing and NGS)
    15,000.00
  • Medizinische Universität Wien
    financial support for newsletters and/or backoffice
    6,000.00
  • St. Anna Kinder Spital
    books for the department library
    900.00
  • Universitätsklinik für Dermatologie
    pillboxes for patients to ensure medication at home
    1,000.00
  • support of PhD Thesis - Establishment and validation of TP-53 mutation screening assays
    pillboxes for patients to ensure medication at home
    30,000.00
  • Verein Focus Gastroenterologie und Hepatologie
    Support HCV project
    20,000.00
Language: Deutsch


This page is intended for visitors outside of the United States.